Qube Research & Technologies LTD Armata Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.4 - $3.9 $49,214 - $79,973	-20,506 Reduced 91.49%	1,908 $5,000
Q1 2024 May 14, 2024	SELL	$2.81 - $4.18 $3,228 - $4,802	-1,149 Reduced 4.88%	22,414 $93,000
Q4 2023 Feb 13, 2024	BUY	$1.95 - $3.24 $41,675 - $69,245	21,372 Added 975.45%	23,563 $76,000
Q3 2023 Nov 13, 2023	BUY	$1.1 - $4.35 $2,410 - $9,530	2,191 New	2,191 $6,000

1.38M

400

17.3K

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $70.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.